Profile data is unavailable for this security.
About the company
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
- Revenue in USD (TTM)268.08bn
- Net income in USD6.15bn
- Incorporated2018
- Employees73.50k
- LocationCigna Group900 Cottage Grove RoadBLOOMFIELD 06002-2920United StatesUSA
- Phone+1 (860) 226-6000
- Fax+1 (302) 655-5049
- Websitehttps://www.thecignagroup.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Centene Corp | 194.78bn | -6.68bn | 19.96bn | 61.10k | -- | 1.00 | -- | 0.1025 | -13.63 | -13.62 | 394.60 | 40.57 | 2.45 | -- | 10.30 | 3,187,840.00 | -8.39 | 0.4683 | -15.18 | 0.771 | 7.12 | 10.08 | -3.43 | 0.2365 | -- | -0.4145 | 0.4646 | -- | 19.44 | 11.88 | -302.06 | -- | -2.47 | -- |
| Tenet Healthcare Corp | 21.31bn | 1.41bn | 20.31bn | 74.48k | 14.92 | 4.81 | 6.29 | 0.9531 | 15.49 | 15.49 | 234.60 | 48.02 | 0.7271 | 10.89 | 8.06 | -- | 8.08 | 7.28 | 11.63 | 10.40 | 82.26 | 82.59 | 11.11 | 10.10 | 1.68 | 6.61 | 0.5948 | -- | 3.12 | 3.85 | -56.03 | 28.67 | 13.34 | -- |
| Humana Inc | 129.66bn | 1.19bn | 22.20bn | 65.68k | 18.77 | 1.26 | 10.43 | 0.1712 | 9.81 | 9.81 | 1,074.55 | 146.42 | 2.72 | -- | -- | -- | 2.74 | 4.86 | -- | -- | -- | -- | 1.01 | 2.05 | -- | 4.79 | 0.4109 | 19.21 | 10.11 | 10.94 | -1.57 | -18.81 | -10.75 | 3.02 |
| Quest Diagnostics Inc | 11.04bn | 988.00m | 22.76bn | 57.00k | 23.61 | 3.17 | 14.46 | 2.06 | 8.76 | 8.76 | 97.87 | 65.18 | 0.6816 | 39.03 | 8.14 | 193,596.50 | 6.20 | 8.03 | 7.25 | 9.31 | 33.32 | 34.94 | 9.10 | 11.33 | 0.9609 | 6.53 | 0.4377 | 29.29 | 11.78 | 3.18 | 14.09 | -7.06 | 4.74 | 7.68 |
| Labcorp Holdings Inc | 13.77bn | 855.20m | 23.43bn | 70.00k | 27.75 | 2.70 | 15.26 | 1.70 | 10.18 | 10.18 | 163.87 | 104.78 | 0.7466 | 19.61 | 6.13 | 196,647.10 | 4.64 | 6.16 | 5.56 | 7.33 | 28.45 | 32.18 | 6.22 | 9.17 | 1.35 | 5.51 | 0.3934 | -- | 6.97 | 2.40 | 96.73 | -1.96 | 4.13 | -- |
| Natera Inc | 2.12bn | -309.19m | 28.70bn | 4.42k | -- | 22.65 | -- | 13.56 | -2.28 | -2.28 | 15.69 | 9.10 | 1.24 | 13.57 | 7.14 | 478,452.50 | -18.12 | -30.60 | -23.17 | -38.82 | 63.66 | 51.43 | -14.61 | -40.61 | 3.13 | -- | 0.0603 | -- | 56.75 | 41.20 | 56.20 | -- | 72.97 | -- |
| Elevance Health Inc | 199.13bn | 5.66bn | 76.54bn | 96.13k | 13.81 | 1.74 | 10.53 | 0.3844 | 25.11 | 25.11 | 886.67 | 198.81 | 1.67 | -- | -- | 2,071,435.00 | 4.75 | 5.60 | -- | -- | -- | -- | 2.84 | 3.52 | -- | 5.79 | 0.4213 | 22.92 | 12.62 | 10.32 | -5.32 | 4.37 | 1.80 | 12.47 |
| Cigna Group | 268.08bn | 6.15bn | 76.78bn | 73.50k | 12.83 | 1.86 | 8.30 | 0.2864 | 22.71 | 22.71 | 988.52 | 156.81 | 1.70 | 45.26 | 9.00 | 3,647,306.00 | 4.15 | 3.91 | 6.50 | 5.49 | 9.55 | 12.70 | 2.44 | 3.12 | 0.7281 | 7.89 | 0.4476 | 19.80 | 26.56 | 9.98 | -33.50 | -7.62 | 6.01 | 169.72 |
| CVS Health Corp | 402.07bn | 1.77bn | 99.84bn | 300.00k | 57.39 | 1.33 | 15.76 | 0.2483 | 1.37 | 1.37 | 316.03 | 59.18 | 1.59 | 18.56 | 39.33 | 1,340,223.00 | 0.682 | 2.24 | 1.04 | 3.26 | 13.77 | 15.33 | 0.4298 | 1.55 | 0.6254 | 3.98 | 0.4614 | 57.26 | 7.85 | 8.39 | -61.68 | -24.46 | 3.05 | 5.87 |
| HCA Healthcare Inc | 75.60bn | 6.78bn | 120.82bn | 230.00k | 19.03 | -- | 10.69 | 1.60 | 28.39 | 28.39 | 315.61 | -26.83 | 1.26 | 6.71 | 6.99 | 328,695.70 | 12.94 | 12.85 | 18.89 | 17.60 | 84.96 | 84.59 | 10.29 | 10.63 | 0.8643 | 5.51 | 1.06 | 10.90 | 7.08 | 7.97 | 17.78 | 12.56 | 11.76 | -- |
| UnitedHealth Group Inc | 447.57bn | 12.06bn | 265.58bn | 400.00k | 22.22 | 2.65 | 15.47 | 0.5934 | 13.19 | 13.19 | 491.02 | 110.49 | 1.47 | -- | -- | -- | 4.21 | 6.98 | -- | -- | -- | -- | 2.86 | 4.89 | -- | 4.74 | 0.4353 | 38.70 | 11.81 | 11.72 | -16.31 | -4.78 | 12.05 | 12.57 |
Data as of Feb 13 2026. Currency figures normalised to Cigna Group's reporting currency: US Dollar USD
40.13%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 23.44m | 8.78% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 13.46m | 5.04% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 12.34m | 4.62% |
| Dodge & Coxas of 31 Dec 2025 | 11.14m | 4.17% |
| T. Rowe Price Associates, Inc. (IM)as of 30 Sep 2025 | 10.90m | 4.08% |
| Massachusetts Financial Services Co.as of 31 Dec 2025 | 9.35m | 3.50% |
| Sanders Capital LLCas of 31 Dec 2025 | 7.80m | 2.92% |
| GQG Partners LLCas of 31 Dec 2025 | 7.76m | 2.91% |
| Geode Capital Management LLCas of 31 Dec 2025 | 6.05m | 2.27% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2025 | 4.95m | 1.85% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
